Lifeward Ltd
For the period ended Dec 31, 2024. Filed Mar 7, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 7, 2025
LFWD$5.94+2.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
SHEETS
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| ASSETS | ||
| CURRENT ASSETS: | ||
| Cash and cash equivalents | $6,746 | $28,083 |
| Restricted cash | 197 | - |
| Trade receivables, net of credit losses of $160 and $328, respectively | 6,004 | 3,120 |
| Prepaid expenses and other current assets | 1,624 | 2,366 |
| Inventories | 6,723 | 5,653 |
| Total current assets | 21,294 | 39,222 |
| LONG-TERM ASSETS | ||
| Restricted cash and other long-term assets | 240 | 784 |
| Operating lease right-of-use assets | 548 | 1,861 |
| Property and equipment, net | 867 | 1,262 |
| Intangible assets, net | ‐ | 12,525 |
| Goodwill | 7,538 | 7,538 |
| Total long-term assets | 9,193 | 23,970 |
| Total assets | $30,487 | $63,192 |
F - 4
CONSOLIDATED BALANCE SHEETS
U.S. dollars in thousands (except share and per share data)
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||
| CURRENT LIABILITIES: | ||
| Trade payables | $5,022 | $5,069 |
| Employees and payroll accruals | 1,332 | 2,034 |
| Deferred revenue | 1,248 | 1,504 |
| Current maturities of operating leases liability | 858 | 1,296 |
| Earnout liability | 608 | 576 |
| Other current liabilities | 1,157 | 1,316 |
| Total current liabilities | 10,225 | 11,795 |
| LONG-TERM LIABILITIES | ||
| Earnout liability | ‐ | 2,716 |
| Deferred revenues | 1,324 | 1,506 |
| Non-current operating leases liability | 22 | 607 |
| Other long-term liabilities | 67 | 58 |
| Total long-term liabilities | 1,413 | 4,887 |
| Total liabilities | 11,638 | 16,682 |
| COMMITMENTS AND CONTINGENT LIABILITIES | ||
| Shareholders’ equity: | ||
| Ordinary share of NIS 1.75 par value-Authorized: 25,000,000 shares at December 31, 2024 and 17,142,857 at December 31, 2023; Issued: 9,382,801 and 9,161,798 shares at December 31, 2024 and December 31, 2023, respectively; Outstanding: 8,808,143 and 8,587,140 shares as of December 31, 2024 and December 31, 2023 respectively (1) | 4,590 | 4,487 |
| Additional paid-in capital | 282,287 | 281,109 |
| Treasury Shares at cost, 574,658 ordinary shares at December 31, 2024 and December 31, 2023 | (3,203) | (3,203) |
| Accumulated deficit | (264,825) | (235,883) |
| Total shareholders’ equity | 18,849 | 46,510 |
| Total liabilities and shareholders’ equity | $30,487 | $63,192 |
F - 5
CONSOLIDATED STATEMENTS OF
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.